Vidar G. Flote - Concepedia

Author

Vidar G. Flote

Also Known As

Flote, Vidar, Flote, Vidar G., V. Flote, V. G. Flote, V. Gordon Flote, V.G. Flote, Vidar Flote, Vidar G Flote, Vidar G. Flote, Vidar Gordon Flote

Publications

561

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital UiT The Arctic University of Norway Fred Hutch Cancer Center University of Oslo Harvard University

About

Vidar G. Flote is an author at Oslo University Hospital specializing in breast cancer, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	136
2	Health Sciences	2	2	36
3	Public Health	1	1	34
4	Biostatistics	1	1	12
5	Clinical Nutrition	1	1	12

Vidar G. Flote

Publications

534

Citations

H-Index

Page 1

	Year	Citations
Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women Hanne Frydenberg, Vidar G. Flote, Ine M. Larsson, Breast Cancer Research	2015	87
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab Ann Rita Halvorsen, Vandana Sandhu, Mette Sprauten, Acta Oncologica	2018	75
Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study Trygve Lofterød, Hanne Frydenberg, Vidar G. Flote, Breast Cancer Research and Treatment	2020	69
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival Hanne Frydenberg, Inger Thune, Trygve Lofterød, Breast Cancer Research and Treatment Breast OncologyBreast Cancer RiskCancer RiskMedicineImmunology	2016	54
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer Vidar G. Flote, Riyas Vettukattil, Tone F. Bathen, Lipids in Health and Disease	2016	41
Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women Anita Iversen, Hanne Frydenberg, Anne-Sofie Furberg, European Journal of Cancer Prevention Hormonal ContraceptiveBreast OncologyReproductive HealthGynecologyKey Factors	2015	34
Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment Sonja Hjellegjerde Brunvoll, Inger Thune, Hanne Frydenberg, Nutrition Journal	2018	25
Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial Jørund Graadal Svestad, Mojgan Heydari, Stine Gyland Mikalsen, Radiotherapy and Oncology Adaptive RadiotherapySurface-guided PositioningRadiation TherapyMedical ImagingMedicine	2022	24
Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study Aske Thorn Iversen, Inger Thune, A. McTiernan, Human Reproduction	2011	21
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment Torfinn Støve Madssen, Inger Thune, Vidar G. Flote, British Journal of Cancer	2018	20

Page 1